Biocept Inc reports results for the quarter ended in September - Earnings Summary

Biocept

15/11/2021 23:43

* Biocept Inc  BIOC.OQ  reported quarterly adjusted earnings of
3 cents​​ per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for earnings of
7 cents per share.
* Revenue rose 165.3% to $17.47 million from a year ago; 
analysts expected $16.07 million. 
* The mean earnings estimate of analysts had risen by
about 116.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Biocept Inc shares had fallen by 1.5% this quarter and
lost 11.0% so far this year.
* The company reported quarterly net income of $427.05 thousand.
* Wall Street's median 12-month price target for Biocept Inc is
$13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 11:43 p.m.
 ​All figures in US dollars unless otherwise stated